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Abstract
Aim: To test the early effect of fructose-induced changes in fatty acid composition and oxidative stress markers in
perivascular adipose tissue (PVAT) upon vascular contractility.
Methods: Adult male Wistar rats were fed a commercial diet without (CD) or with 10% fructose (FRD) in the
drinking water for 3 weeks. We measured plasma metabolic parameters, lipid composition and oxidative stress
markers in aortic PVAT. Vascular contractility was measured in aortic rings sequentially, stimulated with serotonin
(5-HT) and high K
+-induced depolarization using intact and thereafter PVAT-deprived rings.
Results: Comparable body weights were recorded in both groups. FRD rats had increased plasma triglyceride and
fructosamine levels. Their PVAT had an increased saturated to mono- or poly-unsaturated fatty acid ratio, a
significant decrease in total superoxide dismutase and glutathione peroxidase activities and in the total content of
glutathione. Conversely, lipid peroxidation (TBARS), nitric oxide content, and gluthathione reductase activity were
significantly higher, indicating an increase in oxidative stress. In aortic rings, removal of PVAT increased serotonin-
induced contractions, but the effect was significantly lower in rings from FRD rats. This effect was no longer
observed when the two contractions were performed in PVAT-deprived rings. PVAT did not affect the contractions
triggered by high K
+-induced depolarization either in CD or FRD rats.
Conclusions: FRD induces multiple metabolic and endocrine systemic alterations which also alter PVAT and the
vascular relaxant properties of this tissue. The changes in PVAT would affect its paracrine modulation of vascular
function.
Background
The metabolic syndrome (MS) is characterized by cen-
tral adiposity, insulin resistance (IR), impaired glucose
tolerance (IGT) or type 2 diabetes, hypertension and
dyslipidemia. These factors predispose to greater risk for
developing cardiovascular disease [1]. The increased
consumption of unhealthy diets - particularly in
Western societies - and a sedentary behavior have
greatly contributed to the high prevalence of this
condition [2]. In this context, fructose consumption has
largely increased as a result of its addition to soft drinks
and processed food [3].
Sucrose- or fructose-rich diets administered to normal
rats induce metabolic alterations that resemble the pro-
file of the human MS [4-8]; consequently, the fructose-
rich diet (FRD) constitutes a useful model for studying
the role of unbalanced diets in the pathogenesis of the
MS and cardiovascular disease. It has been shown that
FRD promotes decreases in endothelial NO production
[9] and vasorelaxation [10,11] as well as impaired insulin-
induced vasodilation [9]. Further, the FRD model is also
useful to test the effects of different preventive strategies
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mortality.
We have recently shown that rats fed a FRD present
marked changes in plasma lipid and hormone profile,
oxidative damage to lipoprotein fractions and their fatty
acids (FAs), fat content in the liver, and fatty acyl com-
position of total lipids in abdominal adipose tissue.
These multiple abnormalities were associated with sig-
nificant changes in insulin sensitivity and IGT, marked
changes in liver glucose metabolism, decreased pancrea-
tic b-cell mass, and increased production of reactive
oxygen species (ROS) [12-16]. The latter effect, com-
monly described as oxidative stress, contributes to the
development and progression of diabetes micro and
macrovascular complications [17-19]. Supporting our
data, it has been reported that FRD promotes oxidative
damage, reducing antioxidant defenses and enhancing
ROS production [3,12,20-22]. Time-sequential studies
have detected enhanced ROS production as early as one
week after FRD administration in aorta, heart and poly-
morphonuclear cells; besides, vascular and cardiac
hypertrophy together with a rise in blood pressure have
also been observed [23]. It is not known, however,
whether these multiple and early FRD-induced distur-
bances also affect perivascular adipose tissue (PVAT).
The PVAT consists of a thin layer of fat located out-
side the adventitial layer, surrounding most systemic
blood vessels. Originally, it was considered as a simple
mechanical support for vasculature; however, recent stu-
dies have demonstrated that PVAT plays an active mod-
u l a t o r yr o l eo nv e s s e lf u n c t i o ni nap a r a c r i n ef a s h i o n
through the release of either contractile or relaxant sub-
stances which act on the underlying vascular smooth
muscle[24-29]. ROS are among the vasoactive products
released by PVAT [30,31]. Additionally, recent studies
performed in vivo have demonstrated a relationship
between PVAT and insulin resistance: insulin sensitivity
was negatively correlated with the amount of PVAT at
the brachial artery [32].
In an attempt to provide an insight into the relation-
ship of impaired PVAT metabolism/function and vascu-
lar reactivity, we fed normal rats with a FRD for 3 weeks
to test: a) whether FRD reproduces the changes observed
in abdominal adipose tissue (fatty acyl compositional
changes and increased markers of oxidative stress) in
PVAT, and b) the potential effect of these PVAT changes
upon the vascular reactivity of aorta rings from control
and FRD rats in response to different stimuli.
Methods
Materials
Thiobarbituric acid, CoA, N-ethylmaleimide, NAD+,
NADH(H), NADPH(H), standards for oxidized and
reduced glutathione, serotonin (5-HT), organic and
inorganic components for buffer preparations, teraetoxy-
propane and butylated hydroxytoluene were purchased
from Sigma Chemical Co (St. Louis, Mo, USA). Sodium
nitrite (99.8% pure) was from Mallinckrodt (Griesheim,
Germany). All solvents were HPLC-grade and provided
by Carlo Erba (Milano, Italy). Lipid standards for c-gas
liquid chromatography (c-GLC) identification were from
Serdary Research Laboratories (London, Ontario,
Canada). All standards were stored in appropriate sol-
vents under nitrogen atmosphere at -20°C. Concentra-
tions and purities were routinely checked by HPLC and/
or c-GLC. Other chemicals used were reagent grade and
obtained from local commercial sources.
Animals, plasma determinations and characteristics of the
FRD-induced insulin resistance model
Normal male Wistar rats weighing 180-200 g were
maintained in a temperature-controlled environment
(23°C) with a fixed 12-hour light/dark cycle and fed a
standard laboratory rat diet (Ganave, Argentina) for
one week (stabilization period); the compositional ana-
lysis of this diet has been described elsewhere [33].
Rats were fed according to the American Institute of
Nutrition [34]. After that period, rats were divided into
two groups and fed the above mentioned diet and tap
water (control diet, CD) during 3 weeks, or the same
diet with the addition of 10% fructose into the drinking
water (FRD). The fructose solution was freshly pre-
pared and changed daily. In both groups, the relative
FA content in the diet was 1.5% 16:0,2 . 1 %18:0, 26.6%
18:1,5 7 . 3 %18:2 n-6,1 . 4 %18:3 n-3,0 . 2 %20:3 n-6,0 . 2 %
20:4 n-9,0 . 2 %20:1, and other FAs in trace amounts
(< 0.2%) sufficient to cover the animals’ nutritional
requirements. Before sacrifice, blood samples were
obtained from the retroorbital plexus under isoflurane
(Florane, Abbot, Argentine) anesthesia; the samples
were placed into chilled tubes with heparin, rapidly
centrifuged at 4°C at 300 × g, and immediately ana-
l y z e do rs t o r e da t- 2 0 ° C .P l a s m at r i g l y c e r i d e s ,g l u c o s e
and fructosamine were measured using commercial kits
(Bio Systems Diagnostics, Argentina) implemented in
an automated clinical analyzer. Insulin levels were
determined by radioimmunoassay using rat insulin
standard. Insulin resistance was assessed with the
HOMA score, calculated with the formula: fasting
plasma insulin (μU/ml) × fasting plasma glucose
(mmol/l)/22.5, as described by Matthews et al. [35].
All the experimental procedures followed during this
investigation conformed to the Guide for the Care and
Use of Laboratory Animals published by the US
National Institutes of Health (NIH publication no. 85-
23, revised 1996) and to the guidelines established by
the Animal Welfare Committee of La Plata School of
Medicine.
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After sacrifice, thoracic aortas were quickly removed
and placed in Petri dishes with chilled PBS. The adhered
PVAT was dissected under a stereoscopic zoom micro-
scope (Model SMZ645/660, Nikon Instruments Inc.,
Melvilla, NY, USA). Aliquots of fat tissue weighing 60 to
80 mg were homogenized in a buffer solution containing
50 mM Tris-HCl (pH 7.4), 1.15% KCl, 1 mM N-ethyl-
maleimide and 0.1% BHT (v/v) with a glass-teflon
microhomogeneizer. The homogenates were centrifuged
at 4°C (600 × g) for 20 min and the resulting superna-
tants were assayed immediately or stored at -70°C under
argon atmosphere. The extent of lipid peroxidation was
determined by measuring thiobarbituric acid reactive
species (TBARS) by the method of Yagi [36] and
expressed as nmol TBARS/mg wet tissue. Teraetoxypro-
pane (Sigma) was used as standard for calibration.
Glutathione and enzymatic antioxidant activity were
also determined in PVAT. Total glutathione (GSSG +
GSH) was measured following the recycling enzymatic
assay described by Brigelius et al. [37]. Superoxide dis-
mutase activities (SOD) were assayed as described by
Flohé and Ötting [38]. Glutathione peroxidase (GSHPx)
and glutathione reductase (GSHRd) were determined
according to Habig et al. [39] and Carlberg and Manner-
vik [40], respectively.
Nitric oxide (NO) content in the homogenates was
estimated as the sum of nitrates plus nitrites (NOx),
which results as the spontaneous and stable end-point
degradation of NO. NOx level was measured with the
spectrophotometric method described by Miranda et al.
[41] using sodium nitrite as standard.
Lipid composition analysis
Appropriate aliquots of tissue homogenates were pro-
cessed by c-GLC fatty acyl composition analysis. Briefly,
total lipids were extracted by the method of Folch et al.
[42]. c-GLC of fatty acid methyl esters (FAME) was per-
formed as previously reported [43], except that in this
case we used a capillary column (Supelco, Avondale,
PA, USA) mounted on a Hewlett Packard HP 6890 Ser-
ies GC System Plus (Avondale, PA) equipped with a
terminal computer integrator system. FAME were iden-
tified by comparison of their relative retention times
with authentic standards, and mass distribution was cal-
culated electronically by quantification of the peak areas.
Vascular reactivity studies
T h ea o r t a sw e r ec u ti n t o3 - 4m mw i d er i n g sa n dg e n t l y
suspended between two stainless steel wires in a water-
jacketed organ bath containing Krebs-Ringer bicarbo-
nate (KRB) solution with the following composition (in
mM): 130 NaCl, 4.7 KCl, 1.17 Na2HPO4,1 . 1 6M g S O 4,
24.0 NaHCO3,2 . 5C a C l 2 and 6 glucose. The solution
was continuously bubbled with a mixture of 5% CO2
and 95% O2, pH 7.4, and kept at 37°C. The lower wire
was fixed to a vertical plastic rod immersed in the organ
bath, while the upper one was rigidly attached to a force
transducer (Letica TRI-201). Initially, arterial rings were
stretched until attaining a force of ≈ 2 g; thereafter, the
rings were allowed to stabilize for 60 min and washed
with fresh KRB every 20 min. The signals from the
force transducers were amplified and driven into an ana-
log-digital board (DT16EZ, Data Translation, Inc.,
Marlboro, MA, USA) mounted in a desktop computer.
On-line recordings and files for later processing were
obtained with the appropriate software (Labtech Note-
book Pro, Laboratory Technology Corp., Wilmington,
MA, USA).
In some experiments, a high-K
+ KRB solution with the
following composition was used (in mM): 54.7 NaCl, 80
KCl, 1.17 Na2HPO4,1 . 1 6M g S O 4, 24.0 NaCO3 H, 2.5
CaCl2 and 6.0 glucose.
To evaluate the potential modulatory role of adipose
tissue, whereas some rings were dissected to remove the
adherent PVAT, in others PVAT was left intact. In rings
with an intact PVAT, a special protocol was developed
to study the possible FRD-induced modifications on the
relaxant effects of this tissue. For this purpose, a con-
traction was induced by 5 μM 5-HT, which acts through
the activation of membrane receptors of vascular
smooth muscle. Thereafter, the rings were carefully dis-
mounted from the chambers and PVAT was carefully
removed with micro scissors under a stereoscopic zoom
microscope. Afterwards, the rings were remounted in
the chambers as described before (including the 1-h sta-
bilization), and the 5-HT challenge protocol was
repeated. In order to minimize differences among vascu-
lar rings, the results of this second exposure to 5-HT
were presented as paired to the first one, i.e., the change
in the maximal force of the second contraction was
expressed as a percentage of the first one. To test the
effect of a different vessel contraction stimulatory path-
way, we used a similar protocol (challenge of the intact
ring followed by the same stimulus applied to the same
ring after PVAT removal), but muscle contraction was
triggered by high K
+-induced depolarization.
In order to study whether vascular smooth muscle was
affected by the FRD, appropriate controls were per-
formed removing PVAT from CD and FRD rings after
isolation of the aorta; the denuded rings were then sub-
jected to the same two sequential steps of the protocol
described above, including the demounting and remount-
ing step between the two contractions. Although initially
studies were performed using either intact or fat-
deprived aorta rings, we later adopted the above men-
tioned procedure to obtain most consistent and least
dispersed data.
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Results are expressed as means ± SEM. One-way
ANOVA followed by Bonferroni’s test and Student’s
t-test were used for establishing statistically significant
differences between groups. In all instances of statistical
analysis, P < 0.05 was considered significant.
Results
Food intake, body weight and blood parameters
A comparable caloric intake was recorded in both
experimental groups. CD and FRD rats consumed an
average of 19.2 and 13.3 g/animal/day; FRD animals also
consumed 5.26 g fructose (calculated from the amount
of fructose solution drinked daily). Accordingly, the
food composition for CD vs. FRD rats was 45% carbohy-
drates, 43% proteins and 12% lipids vs. 60% carbohy-
drates, 31% proteins and 9% lipids. Consequently, there
was a small but not significant difference in caloric
intake between CD and FRD rats (55.65 ± 4.54 vs. 50.79
± 3.43 kcal/day, respectively), No differences were
detected in initial and final body weight between the
experimental groups.
There were no significant differences in fasting plasma
glucose between groups (FRD vs. CD, 6.28 ± 0.15 vs.
6.05 ± 0.15 mmol/L). FRD rats, however, had signifi-
cantly higher plasma triglyceride, fructosamine and insu-
lin levels (1.61 ± 0.14 vs. 1.13 ± 0.08 mmol/L, P < 0.02;
162.6 ± 3.3 vs. 146.2 ± 5.6 μmol/L, P < 0.03; 1.12 ± 0.04
vs. 0.86 ± 0.10, P < 0.05) as well as HOMA insulin resis-
tance index (7.66 ± 0.31 vs. 5.16 ± 0.21, P < 0.001,
respectively) than CD rats. These results validate the
presence of an early fructose-induced metabolic distur-
bance and glucoxidative state in FRD rats, as described
previously [12,13,15].
PVAT: FA composition, antioxidant defense system,
TBARS and NOx
The FA composition of total lipids extracted from
PVAT of both experimental groups is shown in Table 1.
FRD administration for 3 weeks increased the propor-
tion of saturated myristic (14:0), palmitic (16:0) and
stearic (18:0) acids by 37%, 17% and 24%, respectively.
Conversely, the stearic acid derivative oleic acid (18:1)
showed a significant 22% decrease. The polyunsaturated
fatty acids (PUFAs) of the n-6 family showed an uneven
behavior in FRD rats: the percentages of eicosatrienoic
(20:3n-6) and arachidonic (20:4n-6) FAs decreased sig-
nificantly (66% and 33%, respectively), while the linoleic
(18:2n-6) and alpha and gamma-linolenic (18:3n-3) acid
proportions remained unchanged. Thus, the total
amount of PUFAs decreased significantly in FRD rats.
Accordingly, the ratios of total saturated to mono-
unsaturated FAs and total saturated FAs to PUFAs were
higher in this experimental group.
FRD significantly modified those parameters related to
the antioxidant defense system and the main biomarkers
of oxidative damage (total GSH, TBARS and NOx).
Total SOD and GSHPx activities as well as total glu-
tathione content (GSH + GSSG) were significantly lower
in PVAT homogenates of FRD rats. Conversely, TBARS
content and total NOx and GSH-Rd activity were signifi-
cantly higher in these rats (Table 2).
Vascular reactivity studies
Since it is known that PVAT attenuates the smooth
muscle force development induced by 5-HT [24,25], we
tested its effect (5 μM concentration) upon two paired
contractions (intact and PVAT-deprived rings) of aorta
rings obtained from CD and FRD rats (see above).
Removal of PVAT increased the developed force; as
shown in Figure 1A, the second contraction (ring with-
out PVAT) was bigger than the first one (intact ring). In
the case of aortic rings from FRD animals, however, the
increased force recorded after PVAT removal was signif-
icantly smaller than the one observed in rings obtained
from CD animals (Figure 1A). This effect was no longer
observed when the two contractions were performed in
PVAT-deprived rings (Figure 1B). Additionally, the sec-
ond contractions in these rings showed only a small and
comparable increase in either CD or FRD rats (data not
shown).
A similar experimental protocol was performed using
high extracellular K
+, that triggers smooth muscle cell
contraction by depolarization and subsequent opening
of voltage-operated Ca
2+ channels. Results showed that
PVAT does not affect the force development induced by
depolarization; in fact, the percentage of increase of the
Table 1 Fatty acid composition (mol %) of total lipids of
PVAT from CD and FRD rats
FA CD FRD
14:0 (myristic acid) 1.9 ± 0.13 2.6 ± 0.10 ***
16:0 (palmitic acid) 27.6 ± 1.03 32.3 ± 0.70 **
16:1 (palmitoleic acid) 1.0 ± 0.09 0.5 ± 0.05 ***
18:0 (stearic acid) 19.4 ± 0.65 24.1 ± 0.65 ***
18:1 (oleic acid) 12.8 ± 0.35 10.0 ± 0.20 ***
18:2 n-6 (linoleic acid) 15.4 ± 0.33 15.9 ± 0.60
18:3 n-3 (a and g linolenic acids) 0.2 ± 0.02 0.2 ± 0.01
20:3 n-6 (eicosatrienoic acid) 0.3 ± 0.02 0.1 ± 0.02 ***
20:4 n-6 (arachidonic acid) 21.6 ± 1.53 14.5 ± 0.90 ***
Σ Sat/Σ Mono 3.62 ± 0.08 5.72 ± 0.13 ***
Σ PUFA 37.5 ± 0.74 30.7 ± 0.45 ***
Σ Sat/Σ PUFA 1.31 ± 0.04 1.93 ± 0.03 ***
The values represent the means ± SEM; n = 11 animals for each group.
Asterisks indicate P values for differences between CD and FRD; ***< 0.001,
** < 0.01.
CD: control; FRD: fructose-fed rats; Sat: saturated; Mono: monounsaturated;
PUFA: polyunsaturated fatty acids.
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SOD
(U/mg)
GSH-Px
(U/mg)
GSH-Rd
(U/mg)
TBARS
(nmol/mg)
NOx
(pmol/mg)
GSH + GSSG
(pmol/mg)
CD
a 7.96 ± 0.45 12.14 ± 0.94 19.60 ± 1.10 0.27 ± 0.01 110.18 ± 5.89 88.40 ± 4.42
FRD
b 4.98 ± 0.13 6.22 ± 0.27 26.85 ± 1.15 0.53 ± 0.03 215.38 ± 5.03 47.08 ± 1.98
a vs. b, P < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Values represent the means ± SEM. n = 7 animals for each group. CD: control; FRD: fructose-fed rats; SOD: superoxide dismutase; GSH-Px: glutathione peroxidase;
GSH-Rd: glutathione reductase; TBARS: thiobarbituric acid reactive species; NOx: nitrates plus nitrites; GSH+GSSG: total content of glutathione in PVAT.
Figure 1 Vascular reactivity experiments with and without perivascular adipose tissue in CD and FRD animals. A. Increase in the maximal
force of the second contraction (without PVAT) developed by aortic rings from CD and FRD animals stimulated with 5 μM 5-HT (CD, n = 17; FRD, n =
15) or high-K
+ KRB (CD, n = 20; FRD, n = 17). Results are expressed as the increase of the contraction without PVAT compared to a previous
contraction with PVAT whose maximal force is taken as 100%. The asterisk indicates a statistically significant difference from the CD group. B. Maximal
forces attained by denuded aortic rings (without PVAT) from CD and FRD animals stimulated with 5 μM5 - H T( C D ,n=8 ;F R D ,n=7 )o rh i g h - K
+ KRB
(CD, n = 8; FRD, n = 9).
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the same magnitude as that recorded in PVAT-deprived
rings (Figure 1A). The lack of effect of PVAT on
smooth muscle contractions induced by high extracellu-
lar K
+ was also observed in aortic rings obtained from
F R Da n i m a l s( F i g u r e1 A ) .F u r t h e r m o r e ,n od i f f e r e n c e s
were seen between CD and FRD PVAT-deprived rings
in the maximal force produced by depolarization with
high K
+ (Figure 1B).
Discussion
Blood parameters measured in the FRD- rats model
As already reported, we have currently recorded a signif-
icant increase in plasma fructosamine level in rats fed a
FRD for 3 weeks, indicating an increment in systemic
protein glycosylation [15,19]. Since no differences were
recorded in fasting glucose levels but FRD rats had IGT,
we must assume that these rats present abnormally high
postprandial glucose levels. FRD rats also had higher cir-
culating insulin levels and HOMA score values, thus
supporting the presence of an IR state. Hypertriglyceri-
demia - another IR-inducer [3,12,15,22] - was also pre-
sent in these rats due to a combined effect of excess FA
provision to the liver, decreased esterification in adipose
tissue, and attenuation of the lowering effect of insulin
on hepatic VLDL secretion. Such changes can be
ascribed to a) the increased hepatic de novo lipogenesis
observed during high carbohydrate feeding [44], b) the
inhibition of lipoproteinlipase (LPL) activity reported in
FRD rats [45], and c) the consequent decrease in VLDL
and chylomicron hydrolysis.
PVAT measurements
Lipid composition analysis and PVAT redox state
In line with the above mentioned changes, PVAT fatty
acyl lipid composition showed significant changes in
FRD rats, mainly an increase in saturated FAs and a
decrease in mono- and polyunsaturated FAs, resulting in
ar i s eo ft h es a t u r a t e d / M U F Aa n ds a t u r a t e d / P U F A
ratios. We have previously reported similar changes in
the abdominal adipose tissue of these rats, with
increases in the saturated to unsaturated FAs ratios
associated with decreases in the tissue’sa n t i o x i d a n t
defenses [12,13].
The PVAT redox state was also modified by the fruc-
tose overload, as shown by a) a decreased activity of key
antioxidant enzymes such as SOD and GSH-Px, which
account for the excessive production of superoxide
anion and organic peroxides, respectively, b) a reduction
in glutathione content, the major antioxidant of water-
soluble cellular components, c) an increased GSH-Rd
activity that likely reflects a compensatory mechanism
to return oxidized glutathione to its reduced state, and
d) a higher NO production, which may reflect the
activation of the inducible isoform of NO synthase in
response to the augmented oxidative stress. Altogether,
these alterations decreased the cell capacity to cope with
oxidative stress and are responsible for the recorded
increase in biomarkers of oxidative damage, mainly lipid
peroxidation products, estimated through the TBARS
concentration in PVAT. As mentioned before, excessive
chain breaking produced by reactive species is reflected
in the altered saturated/unsaturated FAs ratio present in
PVAT triglycerides. These changes resemble those
reported in abdominal adipose tissue [12,13,15], thus
suggesting that they are the consequence of a general
rather than a single local gluco-oxidative stress and can
partly explain the association between adipose tissue
and vascular dysfunction.
The presence of increased oxidative stress in different
tissues of IR and diabetic animals has also been reported,
such as a NO synthase dysfunction in Goto-Kakizaki rats,
which could be attenuated by exercise [46], and increased
ROS production in aortas of streptozotcin-diabetic mice,
that was reverted by aminoguanidine administration [47].
Vascular reactivity
It has been reported that IR states and type 2 diabetes
are associated to the development of vascular complica-
tions, mostly related to hyperglycemia, dyslipidemia,
protein glycation and enhanced oxidative stress [48]. All
these alterations are present in FRD rats, and animals
fed with such diet for 8 weeks presented endothelial
dysfunction related to reduced NO synthesis and
increased oxidative stress [49].
In our study, we tested whether the significant FRD-
induced changes on PVAT lipid composition and redox
status affected vessel contractility. For that purpose, we
used both intact and PVAT-deprived aorta rings and
two different stimuli: a) 5-HT, because it induces a
PVAT-dependent relaxant response [24], and b) depo-
larization by high extracellular K
+, because it does not
provoke relaxation in a PVAT-dependent fashion.
Results showed that removal of PVAT increased the
force developed by aortic rings in response to 5-HT;
however, such increase was significantly smaller in rings
from FRD rats. This effect was no longer observed when
the two contractions were performed in PVAT-deprived
rings. On the other hand, no differences were recorded
in rings from CD and FRD rats in the contractile
response to high extracellular K
+, neither using intact
nor PVAT-deprived rings. The latter effect was not
unexpected, since factors released by PVAT would pro-
duce vascular smooth muscle relaxation through the
hyperpolarization achieved by the opening of K
+ chan-
nels [24,26,28], and K
+ channel activation does not
hyperpolarize the cell when the extracellular K
+ concen-
tration is high. Interestingly, there would be regional dif-
f e r e n c e si nt h et y p eo fK
+ channels activated by PVAT
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conductance Ca
2+-activated K
+ channels (BKCa)[ 2 6 ] ,i n
others ATP-sensitive K
+ channels (KATP) [24] or
delayed-rectifier K
+ channels (KV) [28] are the target.
We cannot rule out the possibility that agonists pro-
duced by the PVAT in FRD rats modified the vascular
smooth muscle cells-IP3 receptor properties, as it
occurred in rat models of type 1 diabetes [50].
As already mentioned, there were no differences in the
contractile forces developed by 5-HT or by high extra-
cellular K
+ between CD and FRD rings without PVAT
(Figure 1B). Consequently, the current results suggest
that in FRD rats, at least in the period studied, the para-
crine PVAT function rather than the smooth muscle
function was affected. Comparable results regarding aor-
tic rings without PVAT were reported by Verma et al.
[51]: these authors found that administration of a diet
supplemented with a fructose concentration higher than
ours (66% fructose) for 3 weeks did not affect vascular
reactivity to noradrenaline.
The effect of PVAT upon vascular function could be
ascribed to many molecules produced by this tissue.
ROS, namely superoxide anion [30] and H2O2 [31] are
two of the vasoactive substances released by PVAT.
Thus, the change in the redox state (SOD and others)
produced by the FRD will surely affect their concentra-
tions. However, since superoxide anion promotes vessel
contraction while H2O2 induces its relaxation, the final
outcome will depend on their relative PVAT produc-
tion/release balance. Further experiments are required
to define whether the changes observed in the vascular
response to 5-HT are the consequence of the increased
ROS production/action or just casually associated. In
this regard, it would also be interesting to study whether
FRD administration for a longer period accentuates the
currently described PVAT alterations.
Despite the significant association between gluco-
oxidative stress markers and relaxation changes
recorded, some other factors released by PVAT, such
as leptin [52], could also play a role as a signal in our
m o d e l .I nt h i sr e g a r d ,w eh a v ea l r e a d yr e p o r t e dt h a t
FRD-fed rats have high serum leptin levels and that
their abdominal adipose tissue has a higher expression
of its gene and releases larger amounts of leptin [13].
Considering that all the changes recorded in the para-
meters measured in PVAT are highly similar to those
reported in abdominal adipose tissue, we could there-
fore assume that leptin’s behaviour would follow the
same pattern. Altogether, these results support the
concept of the important role of the crosstalk between
PVAT fat and vascular function [53,54].
Even when we found a great coincidence among
gluco-oxidative stress markers, changes in PVAT com-
position and those measured in vascular properties,
other factors such as hypertension - present in the FRD
model [8] - could also participate in the underlying
mechanism responsible for the latter. Anyhow, and as
part of the complex net of interactions present in this
animal model, the increased formation of ROS also con-
tributes to fructose-induced hypertension.
Final remarks and conclusions
The current results evidence that an increased intake of
fructose induces multiple metabolic and endocrine sys-
temic alterations which are concomitant with significant
changes in PVAT fatty acyl composition and oxidative
stress biomarkers. These changes were similar to those
measured in abdominal adipose tissue in this rat model.
While at this stage (3 weeks of treatment) the vascular
smooth muscle response was still unaffected, alterations
in the vascular relaxant properties dependent on the
PVAT were already evident. These results should contri-
bute to elucidate, at least partly, the strong association
between adipose tissue and vascular dysfunction. They
also suggest that at early stages of this rat model that
resemble the human MS, alterations in the paracrine
function of PVAT precede those of vascular smooth
muscle. Finally, the FRD rat model represents a valuable
experimental tool to study the effect of agents poten-
tially able to prevent or attenuate the vascular pathology
associated with the MS and type 2 diabetes. Further,
high fructose diets certainly promote multiple undesir-
able metabolic and vascular disorders.
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